Note 19 - Segment Data

12 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

(19) Segment Data

The Company consists of a single operating and reportable segment.

Revenues shipped to customers outside of the United States comprised approximately 20.8%, 17.5% and 13.9% of the Company’s consolidated revenues for the years ended December 31, 2023, 2022 and 2021, respectively. One customer comprised approximately 28.1% and 21.5% of the Company’s consolidated revenues for the years ended December 31, 2023 and 2022, respectively. No customer comprised more than 10% of the Company’s consolidated revenues for the year ended December 31, 2021. On December 31, 2023, two customers represented approximately 16.5% and 12.2%, respectively, of gross accounts receivable. On December 31, 2022, one customer represented approximately 10% of gross accounts receivable. Approximately 15.3% of all long-lived assets are located outside of the United States.

The Company’s products are primarily sold to customers within the Medical, Aerospace & Defense, Automotive, and Industrial/Other markets. Sales by market for the years ended December 31, 2023, 2022, and 2021 are as follows (in thousands):

	2023					2022					2021
Market	Net Sales		%			Net Sales		%			Net Sales		%
Medical	$	346,355		86.6	%	$	286,180		80.9	%	$	132,505		67.2	%
Aerospace & Defense		16,990		4.2	%		15,328		4.3	%		16,380		7.9	%
Automotive		16,700		4.2	%		17,487		4.9	%		15,596		7.6	%
Industrial/Other		20,027		5.0	%		34,797		9.8	%		41,839		20.3	%
Net Sales	$	400,072		100.0	%	$	353,792		100.0	%	$	206,320		100.0	%

Certain amounts for the year ended December 31, 2022 and 2021 were reclassified between markets to conform to the current year presentation.